Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Guillonneau, Sophie" or (type any "bookEditor issueEditor" and editor="Guillonneau, Sophie")

Add to list
- Journal Article
- A1
- open access
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma

Claus Bachert (UGent) , Peter Hellings (UGent) , Joaquim Mullol, Robert M Naclerio, Jingdong Chao, Nikhil Amin, Annette Grabher, Brian N Swanson, Jennifer D Hamilton, Sophie Guillonneau, et al.

(2019) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 7(7). p.2447-2449
Add to list
- Conference Paper
- C3
Dupilumab demonstrates rapid and sustained improvements in daily asthma-related symptoms in patients with uncontrolled, moderate-to-severe asthma : data from the Liberty Asthma Quest study

Jo Douglass, David Langton, Jonathan Corren, Mario Castro, Sophie Guillonneau, Jingdong Chao, Nikhil Amin, Neil MH Graham, Ariel Teper and Asif H. Khan (UGent)

(2018) INTERNAL MEDICINE JOURNAL. In Internal Medicine Journal 48(supplement 6). p.22-23
Add to list
- Conference Paper
- C3
Dupilumab improves mental health measures in patients with chronic rhinosinusitis and nasal polyposis (CRSwNP)

Claus Bachert (UGent) , Robert Naclerio, Peter Hellings (UGent) , Sophie Guillonneau, Christine Taniou, Jaman Maroni, Paul Rowe, Leda Mannent, Nikhil Amin, Siddesh Kamat, et al.

(2018) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 52(Supplement 62).
Add to list
- Conference Paper
- C3
Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST

William Busse, Jorge F Maspero, Contance H Katelaris, Dinesh Saralaya, Sophie Guillonneau, Bingzhi Zhang, Christine Taniou, Heribert Staudinger, Jingdong Chao, Nikhil Amin, et al.

(2018) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 52(supplement 62).
Add to list
- Conference Paper
- C3
Dupilumab improves asthma-related patient reported outcomes in asthma patients with chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST

Jonathan Corren, Mario Castro, Jorge F Maspero, Antonio L Valero Santiago, Piotr Kuna, Sophie Guillonneau, Qunming Dong, Christine Taniou, Heribert Staudinger, Jingdong Chao, et al.

(2018) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 52(Supplement 62).

Academic Bibliography

Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma

Dupilumab demonstrates rapid and sustained improvements in daily asthma-related symptoms in patients with uncontrolled, moderate-to-severe asthma : data from the Liberty Asthma Quest study

Dupilumab improves mental health measures in patients with chronic rhinosinusitis and nasal polyposis (CRSwNP)

Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST

Dupilumab improves asthma-related patient reported outcomes in asthma patients with chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST

Contents

Support

Contact